These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Helminth antigens modulate immune responses in cells from multiple sclerosis patients through TLR2-dependent mechanisms. Correale J; Farez M J Immunol; 2009 Nov; 183(9):5999-6012. PubMed ID: 19812189 [TBL] [Abstract][Full Text] [Related]
4. The impact of parasite infections on the course of multiple sclerosis. Correale J; Farez MF J Neuroimmunol; 2011 Apr; 233(1-2):6-11. PubMed ID: 21277637 [TBL] [Abstract][Full Text] [Related]
5. A Trypanosoma cruzi antigen signals CD11b+ cells to secrete cytokines that promote polyclonal B cell proliferation and differentiation into antibody-secreting cells. Montes CL; Acosta-Rodríguez EV; Mucci J; Zuniga EI; Campetella O; Gruppi A Eur J Immunol; 2006 Jun; 36(6):1474-85. PubMed ID: 16688679 [TBL] [Abstract][Full Text] [Related]
6. Multiple sclerosis: reduced proportion of circulating plasmacytoid dendritic cells expressing BDCA-2 and BDCA-4 and reduced production of IL-6 and IL-10 in response to herpes simplex virus type 1. Sanna A; Huang YM; Arru G; Fois ML; Link H; Rosati G; Sotgiu S Mult Scler; 2008 Nov; 14(9):1199-207. PubMed ID: 18653740 [TBL] [Abstract][Full Text] [Related]
7. Interferon-beta regulates cytokines and BDNF: greater effect in relapsing than in progressive multiple sclerosis. Hamamcioglu K; Reder AT Mult Scler; 2007 May; 13(4):459-70. PubMed ID: 17463069 [TBL] [Abstract][Full Text] [Related]
8. Novel function of B cell-activating factor in the induction of IL-10-producing regulatory B cells. Yang M; Sun L; Wang S; Ko KH; Xu H; Zheng BJ; Cao X; Lu L J Immunol; 2010 Apr; 184(7):3321-5. PubMed ID: 20208006 [TBL] [Abstract][Full Text] [Related]
9. Increase in multiple sclerosis activity after assisted reproduction technology. Correale J; Farez MF; Ysrraelit MC Ann Neurol; 2012 Nov; 72(5):682-94. PubMed ID: 23034952 [TBL] [Abstract][Full Text] [Related]
10. Memory and naïve B-cell subsets in patients with multiple sclerosis. Niino M; Hirotani M; Miyazaki Y; Sasaki H Neurosci Lett; 2009 Oct; 464(1):74-8. PubMed ID: 19666086 [TBL] [Abstract][Full Text] [Related]
11. B cell expression of the inhibitory Fc gamma receptor is unchanged in early MS. Comabella M; Montalban X; Kakalacheva K; Osman D; Nimmerjahn F; Tintoré M; Lünemann JD J Neuroimmunol; 2010 Jun; 223(1-2):135-7. PubMed ID: 20399509 [TBL] [Abstract][Full Text] [Related]
12. Immunological mechanisms that associate with oligoclonal IgM band synthesis in multiple sclerosis. Villar LM; Espiño M; Cavanillas ML; Roldán E; Urcelay E; de la Concha EG; Sádaba MC; Arroyo R; González-Porqué P; Alvarez-Cermeño JC Clin Immunol; 2010 Oct; 137(1):51-9. PubMed ID: 20621566 [TBL] [Abstract][Full Text] [Related]
13. Tr1 and naturally occurring regulatory T cells induce IgG4 in B cells through GITR/GITR-L interaction, IL-10 and TGF-beta. Satoguina JS; Adjobimey T; Arndts K; Hoch J; Oldenburg J; Layland LE; Hoerauf A Eur J Immunol; 2008 Nov; 38(11):3101-13. PubMed ID: 18924213 [TBL] [Abstract][Full Text] [Related]
15. Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection. Azoulay D; Urshansky N; Karni A J Neuroimmunol; 2008 Mar; 195(1-2):186-93. PubMed ID: 18329726 [TBL] [Abstract][Full Text] [Related]
16. Production of brain-derived neurotrophic factor by mononuclear cells of patients with multiple sclerosis treated with glatiramer acetate, interferon-beta 1a, and high doses of immunoglobulins. Sarchielli P; Zaffaroni M; Floridi A; Greco L; Candeliere A; Mattioni A; Tenaglia S; Di Filippo M; Calabresi P Mult Scler; 2007 Apr; 13(3):313-31. PubMed ID: 17439900 [TBL] [Abstract][Full Text] [Related]
17. IL-10 suppressor activity and ex vivo Tr1 cell function are impaired in multiple sclerosis. Martinez-Forero I; Garcia-Munoz R; Martinez-Pasamar S; Inoges S; Lopez-Diaz de Cerio A; Palacios R; Sepulcre J; Moreno B; Gonzalez Z; Fernandez-Diez B; Melero I; Bendandi M; Villoslada P Eur J Immunol; 2008 Feb; 38(2):576-86. PubMed ID: 18200504 [TBL] [Abstract][Full Text] [Related]
18. Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro. Lisak RP; Benjamins JA; Nedelkoska L; Barger JL; Ragheb S; Fan B; Ouamara N; Johnson TA; Rajasekharan S; Bar-Or A J Neuroimmunol; 2012 May; 246(1-2):85-95. PubMed ID: 22458983 [TBL] [Abstract][Full Text] [Related]
19. Impact of myelin-specific antigen presenting B cells on T cell activation in multiple sclerosis. Harp CT; Lovett-Racke AE; Racke MK; Frohman EM; Monson NL Clin Immunol; 2008 Sep; 128(3):382-91. PubMed ID: 18599355 [TBL] [Abstract][Full Text] [Related]
20. The role of helper and regulatory T cells in the pathogenesis of vitiligo. Basak PY; Adiloglu AK; Ceyhan AM; Tas T; Akkaya VB J Am Acad Dermatol; 2009 Feb; 60(2):256-60. PubMed ID: 19022528 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]